Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nu Holdings
NU
|
+$90.5M |
| 2 |
SW
Smurfit Westrock
SW
|
+$70M |
| 3 |
Pinduoduo
PDD
|
+$28.2M |
| 4 |
Microsoft
MSFT
|
+$24.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$118M |
| 2 |
Apple
AAPL
|
+$43.5M |
| 3 |
WRK
WestRock Company
WRK
|
+$38.2M |
| 4 |
Danaher
DHR
|
+$27.6M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.62% |
| 2 | Healthcare | 12.18% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Industrials | 9.21% |
| 5 | Communication Services | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Sturm, Ruger & Co
RGR
$601M
| $1.42M | ﹤0.01% |
34,000
-900
| -3% | -$38K |
|
|
CDMO
2052
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.42M | ﹤0.01% |
124,400
| – | – |
|
2053
DXP Enterprises
DXPE
$3B
| $1.41M | ﹤0.01% |
26,500
-600
| -2% | -$30.1K |
|
|
PLYA
2054
DELISTED
Playa Hotels & Resorts
PLYA
| $1.41M | ﹤0.01% |
182,000
-3,400
| -2% | -$26.9K |
|
2055
Amerant Bancorp
AMTB
$1.14B
| $1.41M | ﹤0.01% |
65,937
+18,737
| +40% | +$411K |
|
2056
Herbalife
HLF
$1.28B
| $1.4M | ﹤0.01% |
195,072
| – | – |
|
2057
MarineMax
HZO
$1.15B
| $1.4M | ﹤0.01% |
39,600
| – | – |
|
2058
Xometry
XMTR
$5.42B
| $1.39M | ﹤0.01% |
75,900
| – | – |
|
2059
First Community Bankshares
FCBC
$933M
| $1.39M | ﹤0.01% |
32,279
-400
| -1% | -$16.7K |
|
2060
Tompkins Financial
TMP
$1.45B
| $1.39M | ﹤0.01% |
24,100
| – | – |
|
2061
NB Bancorp
NBBK
$1B
| $1.39M | ﹤0.01% |
+75,000
| New | +$1.33M |
|
|
ARIS
2062
Aris Mining
ARIS
$3.59B
| $1.39M | ﹤0.01% |
+299,600
| New | +$1.32M |
|
2063
Vir Biotechnology
VIR
$1.52B
| $1.39M | ﹤0.01% |
185,200
| – | – |
|
2064
Byline Bancorp
BY
$1.78B
| $1.39M | ﹤0.01% |
51,800
-600
| -1% | -$15.9K |
|
|
DHC
2065
Diversified Healthcare Trust
DHC
$2.03B
| $1.39M | ﹤0.01% |
330,806
| – | – |
|
|
GLDD
2066
DELISTED
Great Lakes Dredge & Dock
GLDD
| $1.38M | ﹤0.01% |
131,000
| – | – |
|
2067
B&G Foods
BGS
$299M
| $1.38M | ﹤0.01% |
155,200
| – | – |
|
2068
Independent Bank Corp
IBCP
$854M
| $1.38M | ﹤0.01% |
41,300
| – | – |
|
2069
Mesa Laboratories
MLAB
$633M
| $1.38M | ﹤0.01% |
10,602
| – | – |
|
2070
HealthStream
HSTM
$849M
| $1.38M | ﹤0.01% |
47,700
| – | – |
|
2071
Pacira BioSciences
PCRX
$924M
| $1.38M | ﹤0.01% |
91,400
| – | – |
|
2072
V2X
VVX
$2.55B
| $1.37M | ﹤0.01% |
24,600
| – | – |
|
2073
Universal Technical Institute
UTI
$1.42B
| $1.37M | ﹤0.01% |
84,500
| – | – |
|
2074
MiMedx Group
MDXG
$612M
| $1.37M | ﹤0.01% |
231,300
| – | – |
|
2075
Miller Industries
MLR
$640M
| $1.37M | ﹤0.01% |
+22,400
| New | +$1.35M |
|
Similar funds
Swiss National Bank's Q3 2024 Portfolio in Review
As of Q3 2024, Swiss National Bank held 2,510 positions worth $154B, up 5.8% from $146B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 3.9%. Swiss National Bank opened 52 new positions and exited 45, leaving the 2,510-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q3 2024 buy was Nu Holdings: 6,729,657 shares worth $91.9M.
- Swiss National Bank added most to Pinduoduo in Q3 2024, an estimated $28.2M increase.
- Swiss National Bank's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $118M.
- Swiss National Bank fully exited WestRock Company in Q3 2024, selling an estimated $38.2M.
- Swiss National Bank's ten largest holdings make up 32% of its $154B portfolio in Q3 2024.
- Swiss National Bank opened 52 new positions and closed 45 in Q3 2024.
- Swiss National Bank's portfolio value rose 5.8% quarter-over-quarter to $154B.
Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.